Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Pro Dex (PDEX) EBITDA Margin (2016 - 2025)

Historic EBITDA Margin for Pro Dex (PDEX) over the last 12 years, with Q4 2025 value amounting to 17.46%.

  • Pro Dex's EBITDA Margin rose 14300.0% to 17.46% in Q4 2025 from the same period last year, while for Dec 2025 it was 15.74%, marking a year-over-year decrease of 10900.0%. This contributed to the annual value of 16.05% for FY2025, which is 27300.0% up from last year.
  • Per Pro Dex's latest filing, its EBITDA Margin stood at 17.46% for Q4 2025, which was up 14300.0% from 16.78% recorded in Q3 2025.
  • Over the past 5 years, Pro Dex's EBITDA Margin peaked at 20.9% during Q1 2025, and registered a low of 6.17% during Q4 2023.
  • Moreover, its 5-year median value for EBITDA Margin was 15.42% (2023), whereas its average is 13.64%.
  • In the last 5 years, Pro Dex's EBITDA Margin skyrocketed by 98600bps in 2024 and then tumbled by -79600bps in 2025.
  • Quarter analysis of 5 years shows Pro Dex's EBITDA Margin stood at 15.75% in 2021, then plummeted by -36bps to 10.08% in 2022, then plummeted by -39bps to 6.17% in 2023, then soared by 160bps to 16.03% in 2024, then rose by 9bps to 17.46% in 2025.
  • Its EBITDA Margin was 17.46% in Q4 2025, compared to 16.78% in Q3 2025 and 7.68% in Q2 2025.